Network origin in Roger Léger first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^
5
| Holding Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Roger Léger via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of British Columbia | College/University | Undergraduate Degree Corporate Officer/Principal | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Defense Sciences Research Council | Corporate Officer/Principal | ||
| Vancouver General Hospital | Corporate Officer/Principal | ||
| The Collings Stevens Family Foundation | Corporate Officer/Principal | ||
| LOOP ENERGY INC. | Electrical Products | Director/Board Member | |
| ACM Properties Ltd. | Founder | ||
ACM Advisors Ltd.
 ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | Investment Managers | Founder | |
Flame Biosciences LLC
 Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder | |
| Georgia Health Sciences University | College/University | Doctorate Degree | |
University of California, Berkeley Foundation
 University of California, Berkeley Foundation Investment Trusts/Mutual FundsMiscellaneous University of California, Berkeley Foundation engages in the provision of philanthropic services.It offers social services and supports the advancement of higher education by securing private financial support. The company was founded by Phoebe Apperson Hearst, Jane Sather, Charles Franklin Doe in 1868 and is headquartered in Berkeley, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
| The Letterman Army Institute of Research | Chief Tech/Sci/R&D Officer | ||
| University of Oxford | College/University | Doctorate Degree | |
| CASSAVA SCIENCES, INC. | Biotechnology | Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| XOMA CORPORATION | Pharmaceuticals: Major | Founder | |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | ||
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| Glaxo Group Research Ltd. | Corporate Officer/Principal | ||
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Manchester | College/University | Undergraduate Degree | |
Vancouver Coastal Health Research Institute
 Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
| United States | 13 |
| Canada | 8 |
| United Kingdom | 5 |
| China | 2 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 6 |
| Commercial Services | 5 |
| Producer Manufacturing | 2 |
| Finance | 2 |
Operational
| Corporate Officer/Principal | 12 |
| Director/Board Member | 9 |
| Chief Tech/Sci/R&D Officer | 5 |
| Founder | 4 |
| Doctorate Degree | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Patrick Scannon | 10 |
| Richard J. White | 9 |
| Allan Collings | 6 |
| Neil E. Reiner | 4 |
| Irwin Kuntz | 1 |
- Stock Market
- Insiders
- Roger Léger
- Company connections
